JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB102859

APC/Cy7® Conjugation Kit - Lightning-Link®

5

(1 Review)

|

(24 Publications)

APC/Cy7® Conjugation Kit - Lightning-Link® (ab102859) offers several standout features:

- Rapid Conjugation: achieve APC/Cy7 labeling in under 4 hours with just 30 seconds of hands-on time.
- High Efficiency: ensures 100% antibody recovery, meaning no loss of valuable antibodies.
- Versatility: suitable for conjugating antibodies, proteins, and peptides. APC/Cy7 labeled antibodies can be used immediately in applications such as Flow cytometry , ELISA, and Immunohistochemistry (IHC) without further purification.
- Confidence: cited in over 20 publications.
8 Images
Flow Cytometry - APC/Cy7® Conjugation Kit - Lightning-Link® (AB102859)
  • Flow Cyt

PubMed

Flow Cytometry - APC/Cy7 Conjugation Kit - Lightning-Link.

Robinson, Andrew P., et al used APC/Cy7® Conjugation Kit - Lightning-Link® (ab102859) as part of characterizing oligodendroglial populations. They used the kit to conjugate APC/Cy7® to Mouse anti-MOG antibody, clone 8-18C5, for use in flow cytometry.
SJL/J mice were immunized with PLP139–151 and scored daily for clinical disease. A cohort of SJL/J mice was sacrificed, and spinal cords were analyzed by flow cytometry (n = 5). (A) Cells were distinguished from debris by forward and side scatter then singlet cells were gated. Live cells were gated by dead cell exclusion, and CNS resident cells were identified as CD45− or CD45low. (B) Oligodendroglial cells were defined by double positive staining : A2B5+PDGFRα+ early OPCs, A2B5+NG2+ intermediate OPCs, NG2+O4+ late OPCs, O4+MOG+ pre-myelinating oligodendrocytes, and GALC+MOG+ mature oligodendrocytes.

Image from Robinson, Andrew P., et al., PloS one, 9(9):e107649. doi: 10.1371/journal.pone.0107649. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Schematic Diagram - APC/Cy7® Conjugation Kit - Lightning-Link® (AB102859)
  • Schematic Diagram

Supplier Data

This illustration demonstrates a general procedure of how Lightning-Link® labeling technology enables the direct labeling of antibodies or proteins.

Simply pipette your antibody or biomolecule of choice into the vial of a lyophilized mixture containing the label of interest and incubate for around 3 hours. Please see the ab102859 protocol booklet for more details.

Learn more about our Lightning-Link® conjugation kits here

Flow Cytometry - APC/Cy7® Conjugation Kit - Lightning-Link® (AB102859)
  • Flow Cyt

PubMed

Taichman, Russell S., et al used APC/Cy7® Conjugation Kit - Lightning-Link® (ab102859) as part of examining Axl and Tyro3 expression during experimental prostate cancer (PCa) progression. They used the kit to conjugate APC/Cy7® to antibodies for use in flow cytometry.
Anti-Axl, anti-Tyro3 and anti-Ki67 antibodies were conjugated to the fluorophores APC-Cy7, PE-Cy5, and Atto390 using our Lightning-Link® Conjugation kits. (A) Experimental model. Human PCa cell lines (PC3Luc, DU145Luc) were implanted s.c. into male SCID mice as a model of a primary (1°) tumor development, and removed after 1 month. At monthly intervals thereafter human PCa cells were identified by anti-HLA staining; proliferative status (Ki67 staining) and Axl or Tyro3 levels were evaluated by FACS. (B) Percent expression of Ki67 by lineage depleted (Lin-) marrow cells or by primary tumor cells at 1 month. (C-D) Percent expression of Axl or Tyro3 by primary tumor cells established with (C) DU145 or (D) PC3 cells or by DTCs recovered from marrow over time.

Image from Taichman, Russell S., et al., PLoS One, 8(4): e61873; doi: 10.1371/journal.pone.0061873. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Flow Cytometry - APC/Cy7® Conjugation Kit - Lightning-Link® (AB102859)
  • Flow Cyt

PubMed

Flow Cytometry - APC/Cy7 Conjugation Kit- Lightning-Link.

Okagawa, Tomohiro, et al used APC/Cy7® Conjugation Kit - Lightning-Link® (ab102859) as part of examining the effect on proliferation of bovine leukemia virus (BLV)-specific T cells of the administration of Boch5D2. They used the kit to conjugate APC/Cy7® to monoclonal anti-TCR1-N24 (δ chain) antibody, clone GB21A, for use in flow cytometry.
T-cell proliferation specific for BLV antigen stimulation. Carboxyfluorescein diacetate succinimidyl ester (CFSE)-labeled peripheral blood mononuclear cells were cultured in triplicate with fetal lamb kidney (FLK)-BLV antigen, control FLK antigen (A), or gp51 peptides (0.1 and 1 μg/ml) (B) for 6 days. The percentage of CFSElow cells in CD4+ and CD8+γδTCR− T cells was measured by flow cytometry. CFSElow cells represent cells proliferated during cultivation. Each dot represents the mean of three independent experiments. Significant differences were determined by Dunnett's multiple-comparison test across the time points. *,#,†P < 0.05 versus 0 dpi in each stimulation.

Image from Okagawa, Tomohiro, et al., Front Immunol., 8:650, doi: 10.3389/fimmu.2017.00650. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Flow Cytometry - APC/Cy7® Conjugation Kit - Lightning-Link® (AB102859)
  • Flow Cyt

PubMed

Flow Cytometry - APC/Cy7; Conjugation Kit ;- Lightning-Link.

Kopanke, Jennifer H., et al used APC/Cy7® Conjugation Kit - Lightning-Link® (ab102859) to identify CD5+/5-ethynyl-2′-deoxyuridine (EdU)+ cells. They used the kit to conjugate APC/Cy7® to Mouse Anti-Feline CD5 antibody for use in cell proliferation assay.
Gating tree used to identify CD5+/5-ethynyl-2′-deoxyuridine (EdU)+ cells. Single cells were identified by plotting side scatter area by side scatter height. Cells aligning linearly were counted as single cells. CD5+ cells were identified from single cells by plotting FL8 (the channel recognizing APC-Cy7) by side scatter area. Finally, CD5+ EdU+ cells were identified from CD5+ cells by plotting FL6 (the channel that detects APC) by FL8.

Image from Kopanke, Jennifer H., et al., Scientific reports; 8(1):8168. doi: 10.1038/s41598-018-26558-3. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Flow Cytometry - APC/Cy7® Conjugation Kit - Lightning-Link® (AB102859)
  • Flow Cyt

PubMed

Okagawa, Tomohiro, et al used APC/Cy7® Conjugation Kit - Lightning-Link® (ab102859) as part of examining PD-1 and LAG-3 expression. They used the kit to conjugate APC/Cy7® to monoclonal anti-TCR1-N24 (δ chain) antibody, clone GB21A, for use in flow cytometry.
Expression of PD-1 and LAG-3 on CD4+ T cells in BLV-infected cattle. A Gating strategy and representative dot plots for expression analyses of PD-1 and LAG-3 on IgM−CD3+CD4+γδTCR− T cells from peripheral blood of BLV-infected cattle (AL and EBL). Values in the quadrants indicate percentages of cells. Percentages of PD-1+LAG-3+CD4+ T cells (B), PD-1+LAG-3−CD4+ T cells (C), and PD-1−LAG-3+CD4+ T cells (D) in CD3+CD4+ T-cell population in peripheral blood from BLV-uninfected (BLV − ; n = 15), AL (n = 22), PL (n = 11), and EBL cattle (n = 7). Bars indicate group median percentage. Significant differences between each group were determined using a Kruskal–Wallis test, where P < 0.05 and P < 0.001, indicated by asterisks (* and ***, respectively).

Image from Okagawa, Tomohiro et al., Vet Res., 49(1):50. doi: 10.1186/s13567-018-0543-9. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Fluorescence Microscopy - APC/Cy7® Conjugation Kit - Lightning-Link® (AB102859)
  • Fluorescence Microscopy

PubMed

Kim, Nayoung, et al used APC/Cy7® Conjugation Kit - Lightning-Link® (ab102859) as part of examining apoptosis in HIV-1-infected CD4+ primary T cells. They used the kit to conjugate APC/Cy7® to anti-PPP2R1B antibody for use in confocal microscopy.
Jurkat T cells expressing tTA alone, TatSF2+tTA, or TatSF2G48-R57A +tTA were stained with antibodies against PPP2R1B (first and forth columns of panels, green), pFOXO3a (second column, red), and FOXO3a (forth column, red).

Image from Kim, Nayoung, et al., PLoS Pathog., 6(9): e1001103. doi: 10.1371/journal.ppat.1001103. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Conjugation - APC/Cy7® Conjugation Kit - Lightning-Link® (AB102859)
  • Conjugation

PubMed

Oliveira BM et al. used ab102903 PE-Cy7® conjugation kit with a mouse anti-bovine CD45RO antibody and ab102859 APC-Cy7® conjugation kit with a mouse anti-Bovine CD62L antibody. This enabled them to run their desired multicolor flow cytometry panel.

Data shows flow cytometry gating strategy used to define γδ T cells (TCRγδ+CD3+CD335−), CD4+ T cells (CD4+CD3+TCRγδ−CD335−), CD8+ T cells (CD8+CD3+TCRγδ−CD335−) and NK cells (CD335+CD3−) in the stromal vascular fraction (SVF) of mesenteric and subcutaneous bovine adipose tissue (MAT and SAT, respectively) and in peripheral blood leukocytes. Dead cells were excluded with Fixable Viability Dye (FVD), lymphocytes were gated based on SSC-A versus FSC-A and singlets were selected from the FSC-A versus FSC-H dot plot.

The flow cytometry gating strategy used to define CD45RO+ and CD62L+ T cell subpopulations is also shown in CD8+ T cells.

Image from Oliveira BM et al., Scientific reports., 9 (1) 3413. Fig 1.; doi: 10.1038/s41598-019-39938-0. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/.

Key facts

Product details

APC/Cy7®Conjugation Kit - Lightning-Link (ab102859) uses a simple and quick process for APC/Cy7 labeling / conjugation of antibodies. It can also be used to conjugate other proteins or peptides.

To conjugate an antibody to APC/Cy7® using this kit:
- add modifier to antibody and incubate for 3 hrs
- add quencher and incubate for 30 mins

The APC/Cy7® conjugated antibody can be used immediately in Flow cytometry and other applications. No further purification is required and 100% of the antibody is recovered for use.
The excitation and emission wavelengths for APC/Cy7® are Ex: 650 nm, Em: 774 nm.

Learn about our antibody labeling kits and their advantages here.

Learn about buffer compatibility below; for incompatible buffers and low antibody concentrations, use our antibody purification and concentration kits.
Custom size conjugation kits up to 100 mg are available on demand. Please contact us to discuss your requirements.

Amount and volume of antibody for conjugation to APC/Cy7®.

Kit size Recommended maximum
amount of antibody
Maximum antibody
volume1
3 x 10 µg 3 x 10 µg 3 x 10 µL
100 µg 1 x 100 µg 1 x 100 µL
3 x 100 µg 3 x 100 µg 3 x 100 µL
1 mg 1 x 1 mg 1 x 1 mL

1 Ideal antibody concentration is 1 mg/mL. 0.5 - 1 mg/mL can be used if the maximum antibody volume is not exceeded. Antibodies > 1 mg/mL or < 0.5 mg/mL should be diluted /concentrated.

Buffer Requirements for Conjugation

Buffer should be pH 6.5-8.5.

Compatible buffer constituents
If a concentration is shown, then the constituent should be no more than the concentration shown. If several constituents are close to the limit of acceptable concentration, then this can inhibit conjugation.

50 mM / 0.6% Tris1 0.1% BSA 50% glycerol
0.1% sodium azide3 PBS Potassium phosphate
Sodium chloride HEPES Sucrose
Sodium citrate EDTA Trehalose

1 Tris buffered saline is almost always ≤ 50 mM / 0.6%

Incompatible buffer constituents

Thiomerosal Proclin Glycine
Arginine Glutathione DTT

If a constituent of the buffer containing your antibody or protein is not listed above, please contact us.

Only purified antibodies are suitable for use, ie. where other proteins, peptides, or amino acids are not present: antibodies in ascites fluid, serum or hybridoma culture media are incompatible.

Storing and handling conjugation kits

Lyophilized Lightning-Link® components are hygroscopic.

Kits are intentionally shipped at ambient temperature with silica gel to avoid exposure to moisture. Upon receipt, store the kit frozen and protect from moisture. Before opening the outer container, allow the lyophilized components to reach room temperature to minimize condensation.

This product is manufactured by Expedeon, an Abcam company, and was previously called Lightning-Link® APC/Cy7 Labeling Kit. 765-0015 is the same as the 1 mg size. 765-0010 is the same as the 3 x 100 µg size. 765-0030 is the same as the 3 x 10 µg size. 765-0005 is the same as the 100 µg size.

What's included?

{ "values": { "3x10g": { "sellingSize": "3 x 10 µg", "publicAssetCode":"ab102859-3x10ug", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB102859-CMP03" }, { "size":"3 x 10 µg", "name":"APC-Cy7 Mix", "number":"AB102859-CMP02" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB102859-CMP01" } ] }, "3x100g": { "sellingSize": "3 x 100 µg", "publicAssetCode":"ab102859-3x100ug", "assetComponentDetails": [ { "size":"3 x 100 µg", "name":"APC-Cy7 Mix", "number":"AB102859-CMP02" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB102859-CMP03" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB102859-CMP01" } ] }, "1mg": { "sellingSize": "1 mg", "publicAssetCode":"ab102859-1mg", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB102859-CMP01" }, { "size":"1 x 1 mg", "name":"APC-Cy7 Mix", "number":"AB102859-CMP02" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB102859-CMP03" } ] }, "100g": { "sellingSize": "100 µg", "publicAssetCode":"ab102859-100ug", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB102859-CMP03", "productcode":"" }, { "size":"1 x 100 µg", "name":"APC-Cy7 Mix", "number":"AB102859-CMP02", "productcode":"" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB102859-CMP01", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Ambient - Cannot Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Product protocols

Target data

Publications (24)

Recent publications for all applications. Explore the full list and refine your search

Nature 644:790-798 PubMed40533564

2025

Kupffer cell programming by maternal obesity triggers fatty liver disease.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Huang,Nora R Balzer,Lea Seep,Iva Splichalova,Nelli Blank-Stein,Maria Francesca Viola,Eliana Franco Taveras,Kerim Acil,Diana Fink,Franzisca Petrovic,Nikola Makdissi,Seyhmus Bayar,Katharina Mauel,Carolin Radwaniak,Jelena Zurkovic,Amir H Kayvanjoo,Klaus Wunderling,Malin Jessen,Mohamed H Yaghmour,Lukas Kenner,Thomas Ulas,Stephan Grein,Joachim L Schultze,Charlotte L Scott,Martin Guilliams,Zhaoyuan Liu,Florent Ginhoux,Marc D Beyer,Christoph Thiele,Felix Meissner,Jan Hasenauer,Dagmar Wachten,Elvira Mass

The European respiratory journal 64: PubMed39147413

2024

Airway-derived emphysema-specific alveolar type II cells exhibit impaired regenerative potential in COPD.

Applications

Unspecified application

Species

Unspecified reactive species

Yan Hu,Qianjiang Hu,Meshal Ansari,Kent Riemondy,Ricardo Pineda,John Sembrat,Adriana S Leme,Kenny Ngo,Olivia Morgenthaler,Kellie Ha,Bifeng Gao,William J Janssen,Maria C Basil,Corrine R Kliment,Edward Morrisey,Mareike Lehmann,Christopher M Evans,Herbert B Schiller,Melanie Königshoff

The Journal of clinical investigation 134: PubMed38954588

2024

Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolism.

Applications

Unspecified application

Species

Unspecified reactive species

Nils Mülling,Felix M Behr,Graham A Heieis,Kristina Boss,Suzanne van Duikeren,Floortje J van Haften,Iris N Pardieck,Esmé Ti van der Gracht,Ward Vleeshouwers,Tetje C van der Sluis,J Fréderique de Graaf,Dominique Mb Veerkamp,Kees Lmc Franken,Xin Lei,Lukas van de Sand,Sjoerd H van der Burg,Marij Jp Welters,Sebastiaan Heidt,Wesley Huisman,Simon P Jochems,Martin Giera,Oliver Witzke,Aiko Pj de Vries,Andreas Kribben,Bart Everts,Benjamin Wilde,Ramon Arens

Frontiers in microbiology 15:1360397 PubMed38638908

2024

Prophylactic treatment with PEGylated bovine IFNλ3 effectively bridges the gap in vaccine-induced immunity against FMD in cattle.

Applications

Unspecified application

Species

Unspecified reactive species

Sarah E Attreed,Christina Silva,Monica Rodriguez-Calzada,Aishwarya Mogulothu,Sophia Abbott,Paul Azzinaro,Peter Canning,Lillian Skidmore,Jay Nelson,Nick Knudsen,Gisselle N Medina,Teresa de Los Santos,Fayna Díaz-San Segundo

Nature communications 14:5627 PubMed37699869

2023

Metabolic heterogeneity of tissue-resident macrophages in homeostasis and during helminth infection.

Applications

Flow Cyt (Intra)

Species

Mouse

Graham A Heieis,Thiago A Patente,Luís Almeida,Frank Vrieling,Tamar Tak,Georgia Perona-Wright,Rick M Maizels,Rinke Stienstra,Bart Everts

Virology journal 19:90 PubMed35619167

2022

Anti-L1 antibody-bound HPV16 pseudovirus is degraded intracellularly via TRIM21/proteasomal pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Meiying Li,Jianmei Huang,Yi Zhu,Ziyi Huang,Guonan Zhang,Jianming Huang

American journal of respiratory cell and molecular biology 64:308-317 PubMed33196316

2020

Flow-Cytometric Analysis and Purification of Airway Epithelial-Cell Subsets.

Applications

Unspecified application

Species

Unspecified reactive species

Luke R Bonser,Kyung Duk Koh,Kristina Johansson,Semil P Choksi,Dan Cheng,Leqian Liu,Dingyuan I Sun,Lorna T Zlock,Walter L Eckalbar,Walter E Finkbeiner,David J Erle

Science advances 5:eaaw9051 PubMed31840058

2019

Epigenetic stabilization of DC and DC precursor classical activation by TNFα contributes to protective T cell polarization.

Applications

Unspecified application

Species

Unspecified reactive species

Alison J Eastman,Jintao Xu,Jennifer Bermik,Nicole Potchen,Aaron den Dekker,Lori M Neal,Guolei Zhao,Antoni Malachowski,Matt Schaller,Steven Kunkel,John J Osterholzer,Ilona Kryczek,Michal A Olszewski

Nature communications 10:2541 PubMed31186414

2019

Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Dieter Henrik Heiland,Vidhya M Ravi,Simon P Behringer,Jan Hendrik Frenking,Julian Wurm,Kevin Joseph,Nicklas W C Garrelfs,Jakob Strähle,Sabrina Heynckes,Jürgen Grauvogel,Pamela Franco,Irina Mader,Matthias Schneider,Anna-Laura Potthoff,Daniel Delev,Ulrich G Hofmann,Christian Fung,Jürgen Beck,Roman Sankowski,Marco Prinz,Oliver Schnell

Scientific reports 9:5042 PubMed30911042

2019

Extracellular vesicles carrying lactate dehydrogenase induce suicide in increased population density of Plasmodium falciparum in vitro.

Applications

Unspecified application

Species

Unspecified reactive species

Ricardo Correa,Lorena Coronado,Zuleima Caballero,Paula Faral-Tello,Carlos Robello,Carmenza Spadafora
View all publications
websiteProtocolBooklet
en
websiteProtocolBooklet
zh

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com